Pearl and Planmeca announced plans to integrate Pearl’s Second Opinion disease detection capabilities within Planmeca’s robust imaging software platform, Planmeca Romexis.
“AI is primed to revolutionize the global dentistry market, and together with Planmeca Romexis®, we’re expanding access to the powerful capabilities of this technology,” said Ophir Tanz, founder and CEO of Pearl. “Our partnership with Planmeca will seamlessly integrate Second Opinion into one of the most popular, powerful, and technologically advanced imaging platforms in dentistry, streamlining clinical efficiencies and steering the industry toward a fully AI-powered future.”
Second Opinion is the first-and-only chairside AI software with global regulatory clearances to assist dentists in the detection of numerous common conditions in bitewing, periapical, and panoramic x-rays of adult teeth in patients as young as 12 years old. For Romexis users, Second Opinion software will provide AI evaluations of 2D intraoral X-ray images directly within the Romexis platform, facilitating streamlined patient communication, enhanced diagnostic capabilities, and a higher standard of dental care delivery. The integration will be available for Romexis users around the world soon.
“We are deeply committed to delivering the most advanced capabilities in digital imaging to dental clinics of all sizes and specialties,” said Helianna Puhlin-Nurminen, vice president of digital imaging and applications at Planmeca. “This collaboration with Pearl will further augment diagnostic consistency, accuracy and transparency in dental care, equipping Romexis users with the most advanced pathology detection and patient communication technology.”
Pearl is leading the global dental AI revolution with groundbreaking computer vision solutions that elevate efficiency, accuracy, and the standard of care in dentistry.
Founded in 2019 by Ophir Tanz, Pearl is backed by Craft Ventures and other leading venture capital firms.
To request a demonstration, please visit hellopearl.com/demo.
About Planmeca USA
Planmeca is one of the world’s leading dental equipment manufacturers, with a product range covering digital dental units, CAD/CAM solutions, world-class 2D and 3D imaging devices, and comprehensive software solutions. Privately owned and headquartered in Helsinki, Finland, the company offers a portfolio of high-tech products distributed in over 120 countries worldwide.
For more information, visit planmeca.com.